| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Replimune Group, Inc. (REPL) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 91 sells. REPL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 533.6K | $5.97M | - | |
| Other | 201.6K | $2.25M | - | |
| Other | 199.7K | $2.23M | - | |
| CFO | 194.4K | $2.17M | - | |
| Other | 78.3K | $875.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2020 | Coffin Robert61 | President &Chief R&D Officer | Sell | 220,000 | $40.04 | $8,808,800.00 | -10.9% | |
| Dec 18, 2020 | Rhodes Jason P78 | Director | Sell | 4,319 | $41.95 | $181,182.05 | -0.1% | |
| Dec 17, 2020 | Rhodes Jason P78 | Director | Sell | 65,029 | $42.28 | $2,749,720.63 | -0.4% | |
| Dec 14, 2020 | Franchi Jean M. | Chief Financial Officer | Sale+OE | 25,000 | $43.45 | $1,086,199.51 | -76.8% | |
| Dec 14, 2020 | Rhodes Jason P78 | Director | Sell | 103,686 | $43.35 | $4,494,442.21 | -0.4% | |
| Dec 10, 2020 | Astley-Sparke Philip47 | Chief Executive Officer | Sell | 50,000 | $43.40 | $2,169,873.59 | -0.5% | |
| Dec 9, 2020 | Love Colin72 | Chief Operating Officer | Sell | 30,000 | $43.75 | $1,312,381.56 | -0.6% | |
| Dec 9, 2020 | Rhodes Jason P78 | Director | Sell | 217,362 | $45.92 | $9,981,231.21 | -0.7% | |
| Dec 8, 2020 | Slattery Joseph P | Director | Sale+OE | 5,200 | $46.00 | $239,200.00 | -43.8% | |
| Dec 7, 2020 | Dhingra Kapil | Director | Sale+OE | 40,000 | $45.56 | $1,822,394.89 | -70.0% |